Update on Admission of Shares

Summary by AI BETAClose X

Hemogenyx Pharmaceuticals plc has announced that the Financial Conduct Authority has scheduled the admission hearing for new ordinary shares for January 5, 2026, with admission expected on January 6, 2026. All other details from the December 18, 2025 announcement remain unchanged.

Disclaimer*

UK 100

Latest directors dealings